COMMUNIQUÉS West-GlobeNewswire

AxoGen, Inc. to Report Third Quarter 2018 Financial Results and Host Conference Call on October 29, 2018
16/10/2018
ALACHUA, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
U.S. FDA Approves Cost Recovery for PLX-PAD under Expanded Access Program in the Treatment of Critical Limb Ischemia
16/10/2018
Pluristem enters into agreement with WideTrial Inc. to conduct the program WideTrial will purchase PLX-PAD cell products from Pluristem Program makes investigational treatment available to CLI patients who are [...]
Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil
16/10/2018
MEDFORD, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received a $10.5 million [...]
Axsome Therapeutics Announces AXS-12 for the Treatment of Narcolepsy
16/10/2018
Narcolepsy is a debilitating, orphan neurological condition with limited treatment options Phase 2 trial set to start in 4Q 2018 with results anticipated in 1H 2019 Conference call and webcast scheduled for today at 8: [...]
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
16/10/2018
WINTER SPRINGS, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market opens on Tuesday, [...]
ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology Meeting in Chicago
16/10/2018
Poster on data from a 611-patient study featuring Imprimis’s MKO Melt to be presented SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmic-focused division of Imprimis Pharmaceuticals, Inc. (NASDAQ: [...]
Emerald Health Therapeutics Files 17 Patent Applications Covering Defined Dose™ Cannabis Products
16/10/2018
Unique Emerald cannabinoid formulations and dosage forms focused on providing consumers precise and differentiated products based on protected intellectual property VICTORIA, British Columbia, Oct. 16, 2018 (GLOBE [...]
Managers' transactions
16/10/2018
Company Announcement No. 16 / 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2018
16/10/2018
Company Announcement Net sales of DARZALEX in the third quarter of 2018 totaled USD 498 million Genmab will receive royalties on worldwide net sales from Janssen Biotech, Inc. Copenhagen, Denmark; October 16, 2018 – [...]
United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement
16/10/2018
RESEARCH TRIANGLE PARK, N.C. and WESTLAKE VILLAGE, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced the closing of their [...]
PotNetwork Holdings, Inc. Releases PCAOB Fully Audited and Reviewed Financial Statements under its Registration As an SEC Reporting Company
16/10/2018
Company’s Financial Records are Officially Verified, Enabling Company Uplisting to OTCQB FT. LAUDERDALE, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink: POTN ) has [...]
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2018 Financial Results
16/10/2018
Conference Call Scheduled for October 23, 2018 at 11:00 am EASTERN DUBLIN, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point- [...]
Transactions in relation to share buyback program
16/10/2018
Announcement NO. 45 October 16, 2018 Transactions in relation to share buyback program Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018 [...]
Stina Syrjänen resigns from Biohit Oyj’s Board of Directors
16/10/2018
Biohit Oyj 16.10.2018 12:20 local time Stina Syrjänen resigns from Biohit Oyj’s Board of Directors Stina Syrjänen has notified Biohit Oyj that she will resign from the company’s Board of Directors. The resignation is [...]
HealthLynked Corp. Announces Release of Its WordPress Online Scheduling Software Application that can Integrate with over 60 Million Websites
16/10/2018
NAPLES, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK), which connects doctors, patients and data to improve healthcare, today announced the release of its WordPress application that allows [...]
RAMSAY GENERALE DE SANTE has received competition clearance for the recommended public offer to the shareholders of Capio
16/10/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC A. THE OFFER IS NOT BEING MADE TO (AND [...]
RAMSAY GENERALE DE SANTE a reçu l'autorisation de l'Autorité de la concurrence dans le cadre de l'offre publique d'achat recommandée faite aux actionnaires de Capio
16/10/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]
Notice of Extraordinary General Meeting in Immunicum AB (publ)
16/10/2018
Press Release 16 October 2018 Notice of Extraordinary General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, hereby summon to Extraordinary General Meeting [...]
Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank
16/10/2018
Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank Proceeds will be used to speed up development of pioneering lead product NBTXR3 and to support the European go- [...]

Pages